Yang H Y, Fujishima H, Toda I, Itoh S, Bissen-Miyajima H, Shimazaki J, Tsubota K
Department of Ophthalmology, Tokyo Dental College, Chiba, Japan.
Am J Ophthalmol. 1998 Jan;125(1):54-8. doi: 10.1016/s0002-9394(99)80234-7.
To analyze the relation between allergic conjunctivitis and the results of photorefractive keratectomy performed with an excimer laser in myopic eyes.
Fifty-seven myopic eyes in 57 Japanese patients were classified into three groups: a normal group (30 eyes of 30 patients), a treatment group composed of eyes with allergic conjunctivitis that were treated with fluorometholone and cromolyn sodium eyedrops from month 3 until the end of the 12- to 18-month follow-up period (16 eyes of 16 patients), and a no-treatment group composed of eyes with allergic conjunctivitis that received no allergic treatment until the end of the follow-up period (11 eyes of 11 patients). Preoperative and postoperative examinations included evaluation of corrected and uncorrected visual acuity and grading of corneal haze.
In the no-treatment group, the mean corneal haze score +/- SD of 0.8 +/- 0.98 was significantly greater than the normal group score of 0.38 +/- 0.49 (P = .02). There was no significant difference in the haze score between the treated and normal groups. A refractive outcome of +/- 1 diopter was obtained in 30 (100%) of the 30 patients in the normal group, 15 (93.8%) of 16 patients in the treatment group, and four (36.4%) of the 11 patients in the no-treatment group. Visual acuity was 20/40 or better after photorefractive keratectomy in 30 patients (100%) in the normal group, 15 patients (93.8%) in the treatment group, and six patients (54.5%) in the no-treatment group.
These findings suggest that untreated allergic conjunctivitis is a significant risk factor for haze and myopic regression after photorefractive keratectomy.
分析过敏性结膜炎与准分子激光角膜切削术治疗近视眼效果之间的关系。
57例日本患者的57只近视眼被分为三组:正常组(30例患者的30只眼);治疗组,由患过敏性结膜炎的眼组成,从第3个月开始用氟米龙和色甘酸钠滴眼液治疗,直至12至18个月随访期结束(16例患者的16只眼);未治疗组,由患过敏性结膜炎的眼组成,在随访期结束前未接受过敏治疗(11例患者的11只眼)。术前和术后检查包括评估矫正和未矫正视力以及角膜混浊分级。
在未治疗组中,平均角膜混浊评分为0.8±0.98,显著高于正常组的0.38±0.49(P = 0.02)。治疗组和正常组之间的混浊评分无显著差异。正常组30例患者中有30例(100%)屈光结果为±1屈光度,治疗组16例患者中有15例(93.8%),未治疗组11例患者中有4例(36.4%)。准分子激光角膜切削术后,正常组30例患者(100%)、治疗组15例患者(93.8%)和未治疗组6例患者(54.5%)的视力达到20/40或更好。
这些发现表明,未经治疗的过敏性结膜炎是准分子激光角膜切削术后发生混浊和近视回退的重要危险因素。